Targeted drug delivery without the normal side effects
Indo-Irish Biotech Startup Secures Funding to Accelerate Cancer and Rare Genetic Disease Therapy
09-Jun-2021 -
CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug ...
cancer
drug delivery
funding
+1